Cargando…

Prognostic factors of adjuvant chemotherapy discontinuation among stage III colon cancer patients: A survey of medical oncologists and a systematic review and meta‐analysis

BACKGROUND: Factors that are prognostic of early discontinuation of adjuvant chemotherapy among stage III colon cancer patients have yet to be described. To address this gap, a survey of medical oncologists and a systematic review and meta‐analysis were conducted. METHODS: A survey was distributed i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boyne, Devon J., O'Sullivan, Dylan E., Heer, Emily V., Hilsden, Robert J., Sajobi, Tolulope T., Cheung, Winson Y., Brenner, Darren R., Friedenreich, Christine M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050079/ https://www.ncbi.nlm.nih.gov/pubmed/31962372 http://dx.doi.org/10.1002/cam4.2843

Ejemplares similares

Association Between Adjuvant Chemotherapy Duration and Survival Among Patients With Stage II and III Colon Cancer: A Systematic Review and Meta-analysis
por: Boyne, Devon J., et al.
Publicado: (2019)

Association of a Shortened Duration of Adjuvant Chemotherapy With Overall Survival Among Individuals With Stage III Colon Cancer
por: Boyne, Devon J., et al.
Publicado: (2021)

Real-world impact of patient-reported outcome measurement on overall survival, healthcare use and treatment discontinuation in cancer patients
por: Yan, Jessie T, et al.
Publicado: (2023)

Understanding Real-World Treatment Patterns and Clinical Outcomes among Metastatic Melanoma Patients in Alberta, Canada
por: O’Sullivan, Dylan E., et al.
Publicado: (2023)

Selection Bias in Real-World Data Studies Used to Support Health Technology Assessments: A Case Study in Metastatic Cancer
por: Jarada, Tamer N., et al.
Publicado: (2023)

Long‐term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta‐analysis
por: Boyne, Devon J., et al.
Publicado: (2018)

Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data
por: Amlani, Adam, et al.
Publicado: (2016)

Impact of the COVID-19 pandemic on cancer diagnoses, stage and survival in Alberta
por: Heer, Emily, et al.
Publicado: (2023)

Understanding Characteristics, Treatment Patterns, and Clinical Outcomes for Individuals with Advanced or Recurrent Endometrial Cancer in Alberta, Canada: A Retrospective, Population-Based Cohort Study
por: Martins, Diana, et al.
Publicado: (2023)

A Real-World Evidence Study Using Alberta-Population-Based Data to Describe Treatment Patterns for Metastatic Castration-Sensitive Prostate Cancer Patients (AWARENESS)
por: Karim, Safiya, et al.
Publicado: (2023)

Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada
por: O’Sullivan, Dylan E., et al.
Publicado: (2021)

Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients
por: Boakye, Daniel, et al.
Publicado: (2021)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer
por: Batra, Atul, et al.
Publicado: (2020)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Aerobic exercise and DNA methylation in postmenopausal women: An ancillary analysis of the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial
por: Boyne, Devon J., et al.
Publicado: (2018)

Intake of dietary fibre and lifetime non-steroidal anti-inflammatory drug (NSAID) use and the incidence of colorectal polyps in a population screened for colorectal cancer
por: Shaw, Eileen, et al.
Publicado: (2017)

Burden on Oncologists When Communicating the Discontinuation of Anticancer Treatment
por: Otani, Hiroyuki, et al.
Publicado: (2011)

Understanding Treatment Patterns and Outcomes among Patients with De Novo Unresectable Locally Advanced or Metastatic Urothelial Cancer: A Population-Level Retrospective Analysis from Alberta, Canada
por: Alimohamed, Nimira, et al.
Publicado: (2022)

Prevalence, Treatment Patterns, and Outcomes of Individuals with EGFR Positive Metastatic Non-Small Cell Lung Cancer in a Canadian Real-World Setting: A Comparison of Exon 19 Deletion, L858R, and Exon 20 Insertion EGFR Mutation Carriers
por: O’Sullivan, Dylan E., et al.
Publicado: (2022)

Treatment for lymphoma and late cardiovascular disease risk: A systematic review and meta‐analysis
por: Stone, Chelsea R., et al.
Publicado: (2019)

Transportability of Overall Survival Estimates From US to Canadian Patients With Advanced Non–Small Cell Lung Cancer With Implications for Regulatory and Health Technology Assessment
por: Ramagopalan, Sreeram V., et al.
Publicado: (2022)

The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients
por: Hsieh, Mei‐Chin, et al.
Publicado: (2016)

Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort study
por: Jongeneel, Gabrielle, et al.
Publicado: (2021)

Development of a definition and rules for causal attribution of post-colonoscopy bleeding
por: Hilsden, Robert J., et al.
Publicado: (2020)

Factors Modifying the Associations of Single or Combination Programmed Cell Death 1 and Programmed Cell Death Ligand 1 Inhibitor Therapies With Survival Outcomes in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis
por: Sati, Neha, et al.
Publicado: (2021)

Developing a Prediction Model for Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Model Building Approaches
por: Basmadjian, Robert B., et al.
Publicado: (2022)

Estimating the Impact of Delayed Access to Oncology Drugs on Patient Outcomes in Canada
por: Vanderpuye-Orgle, Jackie, et al.
Publicado: (2022)

Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
por: Stukalin, Igor, et al.
Publicado: (2023)

Stratification of Stage III colon cancer may identify a patient group not requiring adjuvant chemotherapy
por: Malik, Yasir G., et al.
Publicado: (2020)

Adjuvant Therapy for Colon Cancer: Learning from the Past to Inform the Future
por: Sargent, Daniel, et al.
Publicado: (2010)

Being present: oncologists' role in promoting advanced cancer patients' illness understanding
por: Cohen, Simon M., et al.
Publicado: (2018)

Biosimilars 101: considerations for U.S. oncologists in clinical practice
por: Camacho, Luis H, et al.
Publicado: (2014)

Are treatment strategies of urologic oncologists influenced by the opinions of their colleagues?
por: Moore, M. J., et al.
Publicado: (1990)

Oncologists' attitudes toward KRAS testing: a multisite study
por: Harris, Julie N, et al.
Publicado: (2013)

Opioid prescription patterns among radiation oncologists in the United States
por: Huang, Tina Q., et al.
Publicado: (2020)

Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)
por: Singh, Preet Paul, et al.
Publicado: (2016)

Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs
por: Hao, Zhonglin, et al.
Publicado: (2022)

BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network Meta-analyses
por: Béliveau, Audrey, et al.
Publicado: (2019)

Endocrine toxicity of immune checkpoint inhibitors: essential crosstalk between endocrinologists and oncologists
por: Illouz, Frédéric, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hpe8oc90muq0c50hdnc41th0tp